PHAT
NASDAQStockPhathom Pharmaceuticals, Inc.
$10.13-1.03 (-9.29%)
52-Week Range
$2.29
$18.08
Key Stats
Market Cap
798.2M
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.56
Volume
963.6K
Avg Volume
1.2M
Performance
1M
-20.28%
3M
-29.81%
6M
-10.98%
YTD
-34.95%
1Y
+104.40%
3Y
+42.94%
5Y
-77.19%
Price Chart
ETF Exposure
PHAT is held by 48 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| SURI | Simplify Propel Opportunities ETF | 4.24% |
| XPH | State Street SPDR S&P Pharmaceuticals ETF | 1.28% |
| BBP | Virtus Biotech ETF | 1.17% |
| PTH | Invesco Dorsey Wright Healthcare Momentum ETF | 0.58% |
| DWAS | Invesco Dorsey Wright SmallCap Momentum ETF | 0.55% |
| FTKI | First Trust Small Cap BuyWrite Income ETF | 0.27% |
| PILL | Direxion Daily Pharmaceutical & Medical Bull 3X ETF | 0.25% |
| PQSG | PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF | 0.17% |
| IHE | iShares U.S. Pharmaceuticals ETF | 0.13% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.12% |
| IWC | iShares Micro-Cap ETF | 0.09% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.06% |
| IBB | iShares Biotechnology ETF | 0.04% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.04% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.03% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.03% |
| IWN | iShares Russell 2000 Value ETF | 0.02% |
| NUSC | Nuveen ESG Small-Cap | 0.02% |
| VTWO | Vanguard Russell 2000 ETF | 0.02% |
| IWM | iShares Russell 2000 ETF | 0.01% |
| RSSL | Global X - Russell 2000 ETF | 0.01% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.01% |
| UWM | ProShares - Ultra Russell2000 | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| VHT | Vanguard Health Care ETF | 0.01% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.01% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.01% |
| WSML | iShares MSCI World Small-Cap ETF | 0.01% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.00% |
| SMMD | iShares Russell 2500 ETF | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| AVUQ | Avantis U.S. Quality ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
About PHAT ETF Exposure
Phathom Pharmaceuticals, Inc. (PHAT) is held by 48 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 798.2M, PHAT is a widely held institutional stock. The stock currently trades at $10.13. Investors can gain exposure to PHAT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PHAT, sorted by portfolio weight.